Online citations, reference lists, and bibliographies.
← Back to Search

National Use And Effectiveness Of Beta-blockers For The Treatment Of Elderly Patients After Acute Myocardial Infarction: National Cooperative Cardiovascular Project.

H. Krumholz, M. Radford, Y. Wang, J. Chen, A. Heiat, T. Marciniak
Published 1998 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
CONTEXT Despite the importance of beta-blockers for secondary prevention after acute myocardial infarction (AMI), several studies have suggested that they are substantially underutilized, particularly in older patients. OBJECTIVES To describe the contemporary national pattern of beta-blocker prescription at hospital discharge among patients aged 65 years or older with an AMI, to identify the most important predictors of the prescribed use of beta-blockers at discharge, and to determine the independent association between beta-blockers at discharge and mortality in clinical practice. DESIGN Retrospective cohort study using data created from medical charts and administrative files. SETTING Acute care nongovernmental hospitals in the United States. PATIENTS National cohort of 115015 eligible patients aged 65 years or older who survived hospitalization with a confirmed AMI in 1994 or 1995. MAIN OUTCOME MEASURES Blocker as a discharge medication and mortality in the year after discharge. RESULTS Among the 45308 patients without contraindications to beta-blockers, 22665 (50.0%) had a beta-blocker as a discharge medication. There was significant variation by state, ranging from 30.3% to 77.1 %. Of the 36795 patients who were not receiving beta-blocker therapy on admission, 16006 (43.5%) had therapy initiated on or before discharge. Demographic and clinical variables explained relatively little of the variation in the initiation of beta-blocker therapy. The prescribed use of calcium channel blockers at discharge had a strong negative association with the use of beta-blockers (odds ratio [OR] of beta-blocker use, 0.25; 95% confidence interval [CI], 0.24-0.26). The New England region had significantly higher use of beta-blocker therapy than the rest of the country. Compared with cardiologists, internists had similar rates (OR, 0.94; 95% CI, 0.90-1.00) and general and family practice physicians had lower rates (OR, 0.78; 95% CI, 0.73-0.83). After adjusting for potential confounders, beta-blockers were associated with a 14% lower risk of mortality at 1 year after discharge. The association with lower mortality was present in subgroups stratified by age, sex, and left ventricular ejection fraction. CONCLUSIONS Many ideal patients for beta-blocker therapy are not prescribed these drugs at discharge following AMI. The clinical and demographic characteristics of the patients do not explain much of the variation in the treatment pattern. Geographic factors and physician specialty are independently associated with the decision to use beta-blockers. Elderly patients who are prescribed beta-blockers at discharge have a better survival rate, consistent with the findings of randomized controlled trials of younger and lower-risk populations.
This paper references
Beta blockade during and after myocardial infarction: an overview of the randomized trials.
S. Yusuf (1985)
Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly.
J. Gurwitz (1992)
Impact of clinical trials on the use of beta blockers after acute myocardial infarction and its relation to other risk indicators for death and 1‐year mortality rate
B. Karlson (1994)
Audit of secondary prophylaxis after myocardial infarction
D. Whitford (1994)
Preventing heart attack and death in patients with coronary disease.
S. Smith (1995)
Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project.
E. Ellerbeck (1995)
Process and Outcome of Care for Acute Myocardial Infarction among Medicare Beneficiaries in Connecticut: A Quality Improvement Demonstration Project
T. Meehan (1995)
Cardiologists' practices compared with practice guidelines: use of beta-blockade after acute myocardial infarction.
D. Brand (1995)
Use of Inhaled Corticosteroids and the Risk of Cataracts
R. Cumming (1997)
Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.
S. Soumerai (1997)
Comprehensive reliability assessment and comparison of quality indicators and their components.
E. Huff (1997)
Association of inhaled corticosteroid use with cataract extraction in elderly patients.
E. Garbe (1998)
Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project.
T. Marciniak (1998)
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
T. Ryan (1999)

This paper is referenced by
Left Ventricular Ejection Fraction 1 Year After Acute Myocardial Infarction Identifies the Benefits of the Long-Term Use of β-Blockers
Chan Soon Park (2021)
Development and validation of a risk prediction model for in-hospital major cardiovascular events in patients hospitalised for acute myocardial infarction
Chaoqun Wu (2021)
Implementation and Impact of a Risk-Stratified Prostate Cancer Screening Algorithm as a Clinical Decision Support Tool in a Primary Care Network
Anand Shah (2020)
Rassegne Più rischi meno trattamenti : il paradosso degli anziani con sindromi coronariche acute
C. Greco (2020)
Difficult Decisions in Thoracic Surgery: An Evidence-Based Approach
M. Ferguson (2020)
Kevin Callison (2020)
Adherence to beta‐blockers and long‐term risk of heart failure and mortality after a myocardial infarction
L. Desta (2020)
Regional Variation in the Management and Outcomes of Acute Myocardial Infarction With Cardiogenic Shock in the United States
S. Vallabhajosyula (2020)
Geographic Variation in Process and Outcomes of Care for Patients With Acute Myocardial Infarction in China From 2001 to 2015
Q. Zhong (2020)
Challenges and Controversies in the Management of ACS in Elderly Patients
W. Kayani (2020)
Prognostic Impact of β-Blocker Dose After Acute Myocardial Infarction.
D. Hwang (2019)
Self-perceived evidence-based practice competencies: a survey of faculty and students at a chiropractic institution.
Anjum S Odhwani (2019)
Troubles respiratoires obstructifs du sommeil et orthodontie : primum non nocere
P. Amat (2019)
Geschlechtsspezifische Unterschiede in den präklinischen und klinischen Abläufen bei konsekutiven Primär-PCI Patienten – mögliche Einflüsse auf die Langzeitmortalität
Juliane Ebeling (2019)
Twenty-Year Trends in Outcomes for Older Adults With Acute Myocardial Infarction in the United States
H. Krumholz (2019)
Social Media, Health Policy, and Knowledge Translation.
D. Roland (2018)
Effect of beta-blocker dose on mortality after acute coronary syndrome.
S. Raposeiras-Roubín (2018)
Medication use for acute coronary syndrome in Vietnam
Thang Nguyen (2018)
A Test of Supply-Side Explanations of Geographic Variation in Health Care Use
Kevin Callison (2018)
Risk Factors Associated With Major Cardiovascular Events 1 Year After Acute Myocardial Infarction
Y. Wang (2018)
Stopping β-Blockers After Myocardial Infarction: Not So Fast!
D. Ko (2018)
Coronary Artery Disease in Patients ≥80 Years of Age.
Mahesh V. Madhavan (2018)
Enfermedad coronaria en pacientes de edad ≥ 80 años
M. Madhavan (2018)
Incidence and prognosis of cardiopulmonary arrest due to acute myocardial infarction in 85 consecutive patients.
M. Takahashi (2018)
Heart rate control is associated with reduced cardiovascular events in Asian patients with coronary artery disease treated with bisoprolol (BISO-CAD): results from a multi-national, real-world experience
Yundai Chen (2018)
Adherence to Cardiac Practice Guidelines in the Management of Non-ST-Elevation Acute Coronary Syndromes : A Systematic Literature Review
Osien (2018)
Measuring and Improving Quality of Care
B. Easter (2017)
&bgr;‐blocker dosage and outcomes after acute coronary syndrome
J. E. Allen (2017)
Secondary Prevention Medication Use After Myocardial Infarction in U.S. Nursing Home Residents
A. Zullo (2017)
Association of &bgr;-Blockers With Functional Outcomes, Death, and Rehospitalization in Older Nursing Home Residents After Acute Myocardial Infarction
M. Steinman (2017)
Does heart rate really matter to patients with heart failure?
Robert J H Miller (2017)
Adherence to Cardiac Practice Guidelines in the Management of Non-ST-Elevation Acute Coronary Syndromes: A Systematic Literature Review
J. Engel (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar